miRNAs(miR)	MicroRNAs
ncRNAs	non-coding RNAs
IARC	International Agency for Research on Cancer
NCC	National Cancer Center of China
CT	Computed Tomography
MRI	magnetic resonance
PET	Positron emission computed tomography
CEA	carcinoembryonic antigen
AFP	alpha-fetoprotein
PSA	Prostate cancer specific antigen
CTC	circulating tumor cells
NSCLC	non-small cell lung cancer
RISC	RNA induced silencing complex
pri-miRNA	primary miRNA
pre-miRNA	precursor miRNA
UTR	untranslated region
PTGES3	prostaglandin E synthase 3
FAP	ibroblast activation protein
PD1	programmed cell death 1
PDL1	programmed death ligand 1
LUAD	lung adenocarcinoma
LUSC	lung squamous cell carcinoma
CSF	cerebrospinal fluid
ROC	receiver operating characteristic
AUC	area under the curve
PTEN	phosphatase and tensin homolog
HCC	hepatocellular carcinoma
DFS	disease-free survival
GC	Gastric cancer
ImmiRSig	immune-related nine-miRNA signature
GIMiSig	GI-related miRNA signature
CRC	Colorectal cancer
IAMIPS	immune-associated miRNA prognostic signature
PTM	peritoneal metastasis
LM	Leptomeningeal metastasis
BC	breast cancer
TCGA	The Cancer Genome Atlas
GEO	Gene Expression Omnibus
PCa	Prostatic cancer
BPH	benign prostatic hyperplasia
PSA	prostate specific antigen
ADT	androgen-deprivation therapy
CRPC	castration-resistant prostate cancer
BF	biochemical disorder
CF	clinical failure
PFS	progression-free survival
RFS	relapse free survival
BRC	biochemical relapse
RP	radical prostatectomy
SERS-LFA	surface-enhanced Raman scattering-lateral flow assay
TEP	tumor-educated platelet
SEVs	small extracellular vesicles
EV	extracellular vesicles
EBC	exhaled breath condensate
ACP	acid phosphatase
ER	estrogen receptor
PR	progesterone receptor
DRE	digital rectal examination
FOBT	fecal occult blood test